Clinical Trial Update: Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Juvista (avotermin) to prevent or improve scar appearance after scar revision surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scar

Drugs mentioned

• Juvista (avotermin)

Snippet

Sponsor: Renovo | Conditions: Cicatrix | Phase 2 | Status: UNKNOWN